MedTrace Logo

Communities Helping the Hearing of Infants by Reaching Parents

NCT03875339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2699

Last updated 2025-02-14

Study results available
· View outcomes & findings →

Summary

Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children.

The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.

Conditions

  • Congenital Hearing Loss

Interventions

BEHAVIORAL

Navigator Guidance

Use of a dedicated Navigator to determine if follow-up and compliance rates can be improved for those infants initially demonstrating an abnormal hearing result.

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • Matthew Bush, MD

    lead OTHER

Principal Investigators

  • Matthew L Bush, MD, PhD · Associate Professor, Vice Chair of Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-13
Primary Completion
2023-09-08
Completion
2023-09-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03875339 on ClinicalTrials.gov